Results Highlights

Highlights: FY16 1Q Results (As of August 2, 2016)

  • Net sales: Declined, owing to
    • Impact of optimizing our production configuration associated with restructuring initiatives in the resin business, in addition to the stronger yen, although sales were generally steady across all businesses on the whole
  • Operating income and ordinary income: Declined owing to
    • Impacts of foreign exchange movements and downward revisions to NHI drug reimbursement prices, despite efforts to steadily expand the operating margin by driving growth in existing businesses and executing restructuring initiatives
    • Deterioration of non-operating income and losses, mainly due to foreign exchange losses
  • Profit attributable to owners of parent: Largely unchanged, due to
    • Impact of tax effect accounting, etc.

In the fiscal year 2016, March 31, 2017, consolidated net sales for the 1st quarter amounted to 174.2 billion yen, down -18.3 billion yen compared with 192.6 billion yen for the 1st quarter of fiscal 2015. Operating income for the 1st
quarter of fiscal 2016 were 15.7 billion yen, down -0.7 billion yen compared with 16.4 billion yen for the 1st quarter of fiscal 2015. Ordinary income for the 1st
quarter of fiscal 2016 amounted to 14.4 billion yen, down -3.6 billion yen compared with 18.0 billion yen for the 1st
quarter of fiscal 2015. Profit attributable to owners of parent of 11.4 billion yen for the 1st
quarter of
fiscal 2016 increased +0.2 billion yen compared with profit attributable to owners of parent of 11.2 billion yen in the 1st quarter of fiscal 2015.

Total assets as of June 30, 2016, amounted to 789.8 billion yen, down -33.6 billion yen from the end of fiscal 2015(823.4 billion yen). Shareholders쨈 equity was 290.3 billion yen, decrease of -9.9 billion yen compared with 300.1 billion yen. Interest-bearing debt was down -5.5 billion yen, from 303.3 billion yen at the end of fiscal 2015 to 297.8 billion yen.

* Profit attributable to owners of parent

Financial Results